Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2021 to Question 44360, on Polycystic Ovary Syndrome, if he will provide the data requested in the context of the Answer of 7 November 2016 to Question 51291, on Polycystic Ovary Syndrome.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The information requested on the number of number of women diagnosed with polycystic ovary syndrome is not collected in the format requested. In our earlier answer of 7 November 2016, we provided the number of finished admission episodes (FAE) where the patient is female and a primary diagnosis for polycystic ovary syndrome was made in England. It should be noted that a FAE does not reflect the number of women who have had the syndrome as the same patient can be recorded on more than one occasion. In addition, diagnoses for this condition can occur in non-hospital settings, which is not recorded in this data.
The following table shows FAE activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector in each year from 2015-16 to 2019-2020.
Year | Admissions |
2015-16 | 1,392 |
2016-17 | 1,297 |
2017-18 | 1,223 |
2018-19 | 1,254 |
2019-20 | 1,226 |
Source: Hospital Episode Statistics, NHS Digital
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 25 February 2021 to Question 154803 on Coronavirus: Ivermectin, if he will publish an update on the larger scale studies on the use of ivermectin to treat covid-19.
Answered by Maggie Throup
The Department continues to closely monitor the evidence on ivermectin as a treatment for COVID-19 from clinical trials taking place worldwide. On 23 June 2021, ivermectin was entered into the University of Oxford’s United Kingdom PRINCIPLE clinical trial as a potential treatment for COVID-19 in the community. We await the outcome from this trial early next year.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent steps he has taken to progress the Government's Mental Health recovery plan announced in March 2021.
Answered by Gillian Keegan - Secretary of State for Education
The Department has worked with NHS England and NHS Improvement, Public Health England, Health Education England and other delivery organisations to allocate £500 million of additional funding in 2021-22 to nationally-led programmes and local authority areas. The funding is enabling prevention and promotion activities in local authorities, expanding capacity across specialist mental health services, and training and developing the mental health workforce, in line with the commitments made in the recovery plan.
These programmes are being monitored through a Mental Health Recovery Board established to complement the existing governance of the NHS Long Term Plan commitments for mental health. The cross-Government actions in the recovery plan are monitored through the Mental Health Independent Advisory Oversight Group and the Ministerial Mental Health and Wellbeing Task and Finish Group on a quarterly basis.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many women have had polycystic ovary syndrome in each of the last five years.
Answered by Gillian Keegan - Secretary of State for Education
This data is not held centrally.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of making dental care free for cancer patients.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
No recent assessment has been made. People with cancer are able to apply for help with National Health Service dental charges on a range of grounds, including partial help through the NHS Low Income Scheme. Nearly half of all NHS dental patients, approximately 17.7 million people, were treated free of charge in the 2019/20 financial year.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made a recent assessment of the potential merits of banning the advertising of hybrid nicotine-based products.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
No specific assessment has been made recently. Product standards and requirements of e-cigarettes, including how they are advertised, is regulated by the Tobacco and Related Products Regulations 2016 (TRPR).
The Department will be carrying out a post implementation review of TRPR, and this will include a public consultation on the regulations which will be published shortly. The consultation will provide an opportunity to comment on the current advertising regulations for e-cigarettes.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of missed and late cancelled covid-19 tests for each testing centre in the UK to date.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
We do not publish data in the format requested.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to provide a substantive Answer to Named Day Question 115688, tabled by the hon. Member for Belfast East on 16 November 2020, on Coronavirus: Screening.
Answered by Edward Argar - Minister of State (Ministry of Justice)
We take parliamentary scrutiny incredibly seriously and it is fundamentally important that hon. Members are provided with accurate and timely information to enable them to hold the Government to account. We are working rapidly to provide all Members with accurate answers to their questions, as well as supporting the Government’s response to the unprecedented challenge of the COVID-19 pandemic.
The hon. Member’s question will be answered as soon as possible.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the Government is planning to take to mitigate the effect of the Border Operating Model on the supply of (a) urgent medical supplies and (b) other goods from Great Britain to Northern Ireland after the transition period.
Answered by Edward Argar - Minister of State (Ministry of Justice)
After the end of the transition period, the United Kingdom will have autonomy over the regulation of goods, including medicines. As set out in the Northern Ireland Protocol, which will take effect on 1 January 2021, Northern Ireland will continue to follow the European Union acquis for medicines. The Government has been in intensive discussion with the European Commission on how to safeguard the crucial flows of medicines and medical products into Northern Ireland from other parts of the UK from the end of the transition period.
The parties have agreed a pragmatic approach to implementation, including a one year time-limited approach to the application of the regulatory requirements for imports and the ‘safety feature’ elements of the Falsified Medicines Directive. This was set out in the UK Government statement of 5 November following the fourth meeting of the Ireland/Northern Ireland Specialised Committee. This approach gives industry the time and flexibility it needs and ensure that medicines can continue to flow to Northern Ireland. Further industry guidance on moving medicines to Northern Ireland after the end of the transition period will be published shortly.
Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans the Government has to maintain medical supply lines between Great Britain and Northern Ireland where EU medicine rules will still apply after the transition period.
Answered by Edward Argar - Minister of State (Ministry of Justice)
After the end of the transition period, the United Kingdom will have autonomy over the regulation of goods, including medicines. As set out in the Northern Ireland Protocol, which will take effect on 1 January 2021, Northern Ireland will continue to follow the European Union acquis for medicines. The Government has been in intensive discussion with the European Commission on how to safeguard the crucial flows of medicines and medical products into Northern Ireland from other parts of the UK from the end of the transition period.
The parties have agreed a pragmatic approach to implementation, including a one year time-limited approach to the application of the regulatory requirements for imports and the ‘safety feature’ elements of the Falsified Medicines Directive. This was set out in the UK Government statement of 5 November following the fourth meeting of the Ireland/Northern Ireland Specialised Committee. This approach gives industry the time and flexibility it needs and ensure that medicines can continue to flow to Northern Ireland. Further industry guidance on moving medicines to Northern Ireland after the end of the transition period will be published shortly.